YÜKSEL, S. Et Al. FIRST-LINE AND LONG TERM ECULIZUMAB THERAPY IN ATYPICAL HEMOLYTIC UREMIC SYNDROME; SINGLE CENTER EXPERIENCE. , 1648-1649.

YÜKSEL, S., Evrengül, H., Becerir, T., Yalçin, N., & Koçyigit, A., FIRST-LINE AND LONG TERM ECULIZUMAB THERAPY IN ATYPICAL HEMOLYTIC UREMIC SYNDROME; SINGLE CENTER EXPERIENCE . (pp.1648-1649).

YÜKSEL, SELÇUK Et Al. "FIRST-LINE AND LONG TERM ECULIZUMAB THERAPY IN ATYPICAL HEMOLYTIC UREMIC SYNDROME; SINGLE CENTER EXPERIENCE,"

YÜKSEL, SELÇUK Et Al. "FIRST-LINE AND LONG TERM ECULIZUMAB THERAPY IN ATYPICAL HEMOLYTIC UREMIC SYNDROME; SINGLE CENTER EXPERIENCE." , pp.1648-1649

YÜKSEL, S. Et Al. . "FIRST-LINE AND LONG TERM ECULIZUMAB THERAPY IN ATYPICAL HEMOLYTIC UREMIC SYNDROME; SINGLE CENTER EXPERIENCE." , pp.1648-1649.

@conferencepaper{conferencepaper, author={SELÇUK YÜKSEL Et Al. }, title={FIRST-LINE AND LONG TERM ECULIZUMAB THERAPY IN ATYPICAL HEMOLYTIC UREMIC SYNDROME; SINGLE CENTER EXPERIENCE}, congress name={}, city={}, country={}, year={0}, pages={1648-1649} }